Halozyme Therapeutics | Despesas Operacionais

Operating Expenses Alterar Data
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amarin USD 87.51M 16.62M 2023-09
Amgen USD 6.93B 2.11B 2023-12
Baxter International USD 3.59B 173M 2023-12
Cytokinetics USD 129.09M 6.45M 2023-12
Eli Lilly USD 6.97B 2.08B 2023-12
Halozyme Therapeutics USD 129M 1.25M 2023-12
Intra Cellular Therapies USD 166.2M 10.31M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
MannKind USD 50.61M 4.46M 2023-12
Pfizer USD 20.8B 4.62B 2023-12
United Therapeutics USD 354.6M 72.2M 2023-12



Halozyme Therapeutics Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.